Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.79 is 74% below its 5-year average of 3.06, near the low end of its 5-year range (0.79–5.31).
As of the fiscal period ended Tuesday, June 30, 2026. 20.85% below its 12-month average of 1.00.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.79.
CURRENT RATIO
0.79
CURRENT RATIO AVG TTM
1.00
CURRENT RATIO AVG 3Y
2.33
CURRENT RATIO AVG 5Y
3.06
CURRENT RATIO AVG 10Y
4.62
CURRENT RATIO AVG 15Y
4.98
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.85%
CURRENT VS 3Y AVG
-65.94%
CURRENT VS 5Y AVG
-74.13%
CURRENT VS 10Y AVG
-82.84%
CURRENT VS 15Y AVG
-84.09%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-78.87%
vs the sector median at left
Karyopharm Therapeutics Inc.
Market Cap
$14.80M
Current Ratio
0.79
TTM Avg
1.00
3Y Avg
2.33
5Y Avg
3.06
Market Cap
$14.71M
Current Ratio
26.25
TTM Avg
8.96
3Y Avg
10.61
5Y Avg
33.19
Market Cap
$15.24M
Current Ratio
1.24
TTM Avg
4.22
3Y Avg
12.60
5Y Avg
18.98
Market Cap
$14.18M
Current Ratio
1.84
TTM Avg
8.58
3Y Avg
10.61
5Y Avg
11.66
Market Cap
$15.54M
Current Ratio
1.95
TTM Avg
2.18
3Y Avg
2.79
5Y Avg
2.57
Market Cap
$13.99M
Current Ratio
2.36
TTM Avg
1.96
3Y Avg
1.68
5Y Avg
3.63
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | $14.80M | 0.79 | 1.00 | 2.33 | 3.06 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.71M | 26.25 | 8.96 | 10.61 | 33.19 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | 1.24 | 4.22 | 12.60 | 18.98 |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.18M | 1.84 | 8.58 | 10.61 | 11.66 |
| Vyome Holdings, Inc. (HIND)vs › | $14.11M | 4.37 | 1.46 | 1.74 | 1.95 |
| Jin Medical International Ltd. (ZJYL)vs › | $15.54M | 1.95 | 2.18 | 2.79 | 2.57 |
| Sintx Technologies, Inc. (SINT)vs › | $13.99M | 2.36 | 1.96 | 1.68 | 3.63 |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.85M | N/A | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 2.09 | 1.13 | 1.21 | 2.30 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | 1.11 | 2.09 | 1.19 | 1.02 |
Current Ratio
0.79
Quick Ratio
0.76
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.79 |
| 2026-03-31 | 1.08 |
| 2025-12-31 | 1.12 |
| 2025-09-30 | 1.03 |
| 2025-06-30 | 0.99 |
| 2025-03-31 | 1.33 |
| 2024-12-31 | 1.70 |
| 2024-09-30 | 3.00 |
| 2024-06-30 | 3.62 |
| 2024-03-31 | 3.04 |
| 2023-12-31 | 3.37 |
| 2023-09-30 | 4.24 |
| 2023-06-30 | 4.94 |
| 2023-03-31 | 5.17 |
| 2022-12-31 | 5.31 |
| 2022-09-30 | 3.61 |
| 2022-06-30 | 3.88 |
| 2022-03-31 | 4.17 |
| 2021-12-31 | 3.74 |
| 2021-09-30 | 3.51 |
| 2021-06-30 | 4.71 |
| 2021-03-31 | 4.12 |
| 2020-12-31 | 4.59 |
| 2020-09-30 | 5.42 |
| 2020-06-30 | 6.29 |
| 2020-03-31 | 7.46 |
| 2019-12-31 | 6.01 |
| 2019-09-30 | 7.16 |
| 2019-06-30 | 6.93 |
| 2019-03-31 | 6.19 |
| 2018-12-31 | 7.13 |
| 2018-09-30 | 5.09 |
| 2018-06-30 | 6.69 |
| 2018-03-31 | 2.85 |
| 2017-12-31 | 3.00 |
| 2017-09-30 | 5.75 |
| 2017-06-30 | 8.32 |
| 2017-03-31 | 7.25 |
| 2016-12-31 | 7.99 |
| 2016-09-30 | 8.71 |
| 2016-06-30 | 8.00 |
| 2016-03-31 | 10.45 |
| 2015-12-31 | 11.74 |
| 2015-09-30 | 13.74 |
| 2015-06-30 | 15.98 |
| 2015-03-31 | 16.96 |
| 2014-12-31 | 16.89 |
| 2014-09-30 | 37.11 |
| 2014-06-30 | 23.96 |
| 2014-03-31 | 29.42 |
| 2013-12-31 | 47.98 |
| 2013-09-30 | 13.41 |
| 2013-06-30 | 24.47 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.49 |
| 2012-09-30 | 0.00 |
